Exploiting Temozolomide-Induced Hypermutation With...

JCO Precision Oncology 2020 / 06 Iss. 4

Exploiting Temozolomide-Induced Hypermutation With Pembrolizumab in a Refractory High-Grade Neuroendocrine Neoplasm: A Proof-of-Concept Case

Klempner, Samuel J., Hendifar, Andrew, Waters, Kevin M., Nissen, Nicholas, Vail, Eric, Tuli, Richard, Mita, Alain
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
JCO Precision Oncology
DOI:
10.1200/PO.20.00034
Date:
June, 2020
File:
PDF, 978 KB
2020
Conversion to is in progress
Conversion to is failed